腹腔镜与开腹肝切除治疗肝内胆管癌:国际多中心倾向评分匹配队列研究
该研究基于2000至2018年3个国际数据库回顾性分析855例肝内胆管癌手术患者,其中开腹709例、腹腔镜146例,经1:1倾向评分匹配后各组89例。调整Cox回归显示严重术后并发症和脂肪变性是死亡预测因素,输血和严重并发症是复发预测因素。结论认为腹腔镜的生存优势因历史偏倚和数据缺失而不明确。
要点
- 严重术后并发症和脂肪变性是死亡的独立预测因素。
- 输血和严重术后并发症是复发的独立预测因素。
核心结论
- 腹腔镜肝切除治疗肝内胆管癌的生存优势因历史偏倚和数据缺失而不明确。
研究设计与样本
- 回顾性分析2000至2018年3个国际数据库中共855例肝内胆管癌手术患者,开腹709例(82.9%)、腹腔镜146例(17.1%)。
- 通过倾向评分按1:1匹配,每组89例,匹配后术前和术后变量无显著差异。
临床怎么用
- 腹腔镜肝切除可用于肝内胆管癌,但需警惕严重术后并发症和输血对生存与复发的不利影响。
局限性
- 研究为回顾性设计,存在历史偏倚和数据缺失,生存优势结论不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intrahepatic cholangiocarcinoma is a rare disease with a poor prognosis. In patients where surgical resection is possible, outcome is influenced by perioperative morbidity and lymph node status. Laparoscopic liver resection is associated with improved clinical and oncological outcomes in primary and metastatic liver cancer compared with open liver resection, but evidence on intrahepatic cholangiocarcinoma is still insufficient. The primary aim of this study was to compare overall survival for a large series of patients treated for intrahepatic cholangiocarcinoma by open or laparoscopic approach. Secondary objectives were to compare disease-free survival, predictors of death, and recurrence. METHODS: Patients treated with laparoscopic or open liver resection for intrahepatic cholangiocarcinoma from 2000 to 2018 from 3 large international databases were analyzed retrospectively. Each patient in the laparoscopic resection group (case) was matched with 1 open resection control (1:1 ratio), through a propensity score calculated on clinically relevant preoperative covariates. Overall and disease-free survival were compared between the matched groups. Predictors of mortality and recurrence were analyzed with Cox regression, and the Textbook Outcomes were described. RESULTS: During the study period, 855 patients met the inclusion criteria (open liver resection = 709, 82.9%; laparoscopic liver resection = 146, 17.1%). Two groups of 89 patients each were analyzed after propensity score matching, with no significant difference regarding pre- and postoperative variables. Overall survival at 1, 3, and 5 years was 92%, 75%, and 63% in the laparoscopic liver resection group versus 92%, 58%, and 49% in the open liver resection group (P = .0043). Adjusted Cox regression revealed severe postoperative complications (hazard ratio: 10.5, 95% confidence interval [1.01-109] P = .049) and steatosis (hazard ratio: 13.8, 95% confidence interval [1.23-154] P = .033) as predictors of death, and transfusion (hazard ratio: 19.2, 95% confidence interval [4.04-91.4] P < .001) and severe postoperative complications (hazard ratio: 4.07, 95% confidence interval [1.15-14.4] P = .030) as predictors of recurrence. CONCLUSION: The survival advantage of laparoscopic liver resection over open liver resection for intrahepatic cholangiocarcinoma is equivocal, given historical bias and missing data.
引用
- Brustia R, Laurent A, Goumard C, et al. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Report of an international multicenter cohort study with propensity score matching. Surgery. 2021. PMID: 34535270. doi:10.1016/j.surg.2021.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。